Center for Psychotherapy Research, Department of Psychiatry, University of Pennsylvania, 3535 Market Street, Philadelphia, PA 19104, USA.
Drug Alcohol Depend. 2010 Jan 15;106(2-3):164-72. doi: 10.1016/j.drugalcdep.2009.08.009. Epub 2009 Sep 25.
The NIDA Collaborative Cocaine Treatment Study yielded different efficacies for different psychosocial treatments for cocaine dependence. However, substantial heterogeneity of patient outcomes was evident. Longitudinal data analysis techniques can be helpful in examining differential effects of psychosocial interventions on specific subpopulations of patients.
Overall drug and cocaine use of 346 patients diagnosed with DSM-IV cocaine dependence and treated with one of four psychosocial interventions were assessed monthly during 6-month treatment. Growth mixture models were used to identify patient subgroups based on typical patterns of change in substance use during treatment and to evaluate differential treatment effects within these subgroups.
Three patient subgroups following different change patterns in cocaine and overall drug use were identified irrespective of the treatment type: (a) those with moderate baseline severity of drug use and very rapid reduction of drug use during treatment, (b) those with moderate baseline severity of drug use and moderate reduction of drug use during treatment, and (c) those with severe levels of baseline drug use with moderate reduction of drug use during treatment. Patient baseline characteristics enabled discrimination between these subgroups. Individual drug counseling was most efficacious among those patients with moderate baseline severity and moderate treatment response. There were no differential treatment effects in the two other patient subgroups.
The population of treatment-seeking cocaine dependent individuals is heterogeneous. Research on patient subgroups with different change patterns revealed its potential to enable classifications of patients that indicate which treatment is most effective for which type of patient.
国家药物滥用研究所合作可卡因治疗研究针对可卡因依赖的不同心理社会治疗方法产生了不同的疗效。然而,患者结果存在明显的异质性。纵向数据分析技术有助于检查心理社会干预对特定患者亚群的不同影响。
对 346 名被诊断为 DSM-IV 可卡因依赖并接受四种心理社会干预之一治疗的患者进行了整体药物和可卡因使用情况评估,每月评估一次,为期 6 个月的治疗期间。使用增长混合模型根据治疗期间物质使用变化的典型模式识别患者亚组,并评估这些亚组内的差异治疗效果。
无论治疗类型如何,都确定了可卡因和整体药物使用存在不同变化模式的三个患者亚组:(a)基线药物使用严重程度适中且治疗期间药物使用迅速减少的患者,(b)基线药物使用严重程度适中且治疗期间药物使用中度减少的患者,以及(c)基线药物使用严重程度较高且治疗期间药物使用中度减少的患者。患者基线特征可区分这些亚组。在基线严重程度适中且治疗反应适度的患者中,个体药物咨询效果最佳。在另外两个患者亚组中没有差异治疗效果。
寻求治疗的可卡因依赖个体人群存在异质性。对不同变化模式的患者亚组的研究表明,它有可能对患者进行分类,指示哪种治疗对哪种类型的患者最有效。